BRIEF published on 04/07/2026 at 07:35, 1 month 5 days ago Evotec propose Dieter Weinand comme nouveau président du conseil de surveillance Partenariats Stratégiques Conseil De Surveillance Evotec Leadership Pharmaceutique Dieter Weinand
BRIEF published on 04/07/2026 at 07:35, 1 month 5 days ago Evotec Proposes Dieter Weinand as New Supervisory Board Chairman Strategic Partnerships Supervisory Board Evotec Pharmaceutical Leadership Dieter Weinand
PRESS RELEASE published on 04/07/2026 at 07:30, 1 month 5 days ago Evotec Nominates Dieter Weinand as Supervisory Board Chairman Evotec SE nominates Dieter Weinand as Supervisory Board Chairman, aiming to enhance commercial execution, strategic partnerships, and profitability Strategic Partnerships Supervisory Board Chairman Evotec SE Commercial Execution Dieter Weinand
BRIEF published on 04/01/2026 at 11:15, 1 month 11 days ago Evotec SE publiera ses résultats financiers de 2025 Résultats Financiers Evotec SE Webdiffusion Découverte De Médicaments Performances 2025
BRIEF published on 04/01/2026 at 11:15, 1 month 11 days ago Evotec SE to Release 2025 Financial Results Financial Results Drug Discovery Evotec SE Webcast 2025 Performance
PRESS RELEASE published on 04/01/2026 at 11:10, 1 month 11 days ago Evotec SE to Announce Fourth Quarter and Full-Year 2025 Results on April 8, 2026 Evotec SE will announce its Q4 and full-year 2025 financial results on April 8, 2026, through a webcast and conference call held in English. Learn more at www.evotec.com Financial Results Conference Call Drug Discovery Evotec SE Webcast
BRIEF published on 04/01/2026 at 07:35, 1 month 11 days ago Evotec Appoints Dr. Ashiq H. Khan as Chief Commercial Officer AI Innovation Biotech Leadership Evotec Commercial Strategy
BRIEF published on 04/01/2026 at 07:35, 1 month 11 days ago Evotec nomme le Dr Ashiq H. Khan au poste de directeur commercial Biotechnologie Direction Stratégie Commerciale Evotec Innovation En IA
PRESS RELEASE published on 04/01/2026 at 07:30, 1 month 11 days ago Evotec Appoints Dr. Ashiq H. Khan as Chief Commercial Officer Evotec SE appoints Dr. Ashiq H. Khan as Chief Commercial Officer, bringing over 15 years of international leadership experience in biotech, CRO, and AI-driven platforms Chief Commercial Officer Evotec SE Biotech AI-driven Platforms Dr. Ashiq H. Khan
BRIEF published on 03/23/2026 at 07:35, 1 month 20 days ago Evotec Biologics Partners with BARDA to Enhance Antibody Production Against Ebola Evotec BARDA Biomanufacturing Ebola Antibodies
Published on 05/12/2026 at 21:55, 30 minutes ago UraniumX Discovery Corp Announces Option Agreement with Gold'n Futures
Published on 05/12/2026 at 21:42, 43 minutes ago Kidoz Inc. to Present at Planet MicroCap Las Vegas 2026
Published on 05/12/2026 at 14:30, 7 hours 55 minutes ago Pathfinder Ventures Inc. Announces Conclusion of Financing and Intention to Launch New Private Placement
Published on 05/12/2026 at 14:30, 7 hours 55 minutes ago ACCESS Newswire Reports First Quarter 2026 Results
Published on 05/12/2026 at 13:50, 8 hours 35 minutes ago Polaris Renewable Energy Announces Approval of SO1 Agreement by FOMB
Published on 05/12/2026 at 20:21, 2 hours 3 minutes ago Nebius breaks ground on gigawatt-scale AI factory in Independence, Missouri
Published on 05/12/2026 at 19:35, 2 hours 50 minutes ago AUSTRIACARD HOLDINGS AG: Q1 2026 Financial Results
Published on 05/12/2026 at 19:35, 2 hours 50 minutes ago 2026 Annual General Meeting: Strong vote by shareholders in favour of continuity in leadership and strategy
Published on 05/12/2026 at 18:46, 3 hours 38 minutes ago LION E-Mobility Reports Q1 Results and Confirms Fiscal 2026 Outlook
Published on 05/12/2026 at 18:45, 3 hours 40 minutes ago Antitrust authority approval granted for the acquisition of a portfolio of rental units in Poland
Published on 05/12/2026 at 18:15, 4 hours 10 minutes ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 30/04/2026
Published on 05/12/2026 at 18:15, 4 hours 10 minutes ago AXA: Information relating to the number of voting rights and shares making up the share capital on 30/04/2026
Published on 05/12/2026 at 18:10, 4 hours 15 minutes ago imerys-12-05-2026-communiqué-compte-rendu-de-l-assemblée-générale-ordinaire-du-12-mai-2026
Published on 05/12/2026 at 18:10, 4 hours 15 minutes ago imerys-12-05-2026-press-release-summary-of-the-ordinary-shareholders-general-meeting-12-may-2026
Published on 05/12/2026 at 17:50, 4 hours 35 minutes ago Damartex fait évoluer sa gouvernance et engage une réflexion stratégique autour de ses activités
